Skip to Main Content

Author Details

James Y Dai
Fred Hutchinson Cancer Center
2005
74
20
PMIDPaper TitleJournal TitlePublished Year
36874058Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.Eur J Gynaecol Oncol2023
37555839Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study.Cancer Epidemiol Biomarkers Prev2023
34505128Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.Hum Mol Genet2022
35709760eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.Cancer Epidemiol Biomarkers Prev2022
35766871A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets.Hum Mol Genet2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
35400115A multiple-testing procedure for high-dimensional mediation hypotheses.J Am Stat Assoc2022
34888857Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associations.Int J Cancer2022
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33707472EMeth: An EM algorithm for cell type decomposition based on DNA methylation data.Sci Rep2021
34531249Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.J Immunother Cancer2021
34230610Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.Br J Cancer2021
33972368Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study.Cancer Epidemiol Biomarkers Prev2021
33436325Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.Eur Urol Oncol2021
33300568Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.Carcinogenesis2021
32226005DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.PLoS Genet2020
32071439Copy number alterations are associated with metastatic-lethal progression in prostate cancer.Prostate Cancer Prostatic Dis2020
30476131Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.Int J Epidemiol2019
32489221Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous endpoints.J R Stat Soc Ser C Appl Stat2019
31248371Interactive decision support for esophageal adenocarcinoma screening and surveillance.BMC Gastroenterol2019
30908669Best linear inverse probability weighted estimation for two-phase designs and missing covariate regression.Stat Med2019
30464020Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the <i>CRACR2A</i> Gene.Cancer Epidemiol Biomarkers Prev2019
30538099Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.Cancer Prev Res (Phila)2019
28550377Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.AIDS Behav2018
30188971Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.Am J Epidemiol2018
29956356A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer.Prostate2018
29894562Identifying disease-associated copy number variations by a doubly penalized regression model.Biometrics2018
30374464Whole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterations.Commun Biol2018
29767639Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.J Acquir Immune Defic Syndr2018
29795306Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer.Br J Cancer2018
28960244Case-only approach to identifying markers predicting treatment effects on the relative risk scale.Biometrics2018
28954280Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk.J Natl Cancer Inst2017
29250210Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data.Ann Appl Stat2017
26123563Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.J Infect Dis2016
26347982Augmented case-only designs for randomized clinical trials with failure time endpoints.Biometrics2016
26420797Group association test using a hidden Markov model.Biostatistics2016
27658440A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy.J Int AIDS Soc2016
27378290TwoPhaseInd: an R package for estimating gene-treatment interactions and discovering predictive markers in randomized clinical trials.Bioinformatics2016
27401570Detectable Tenofovir Levels in Breast-Feeding Infants of Mothers Exposed to Topical Tenofovir.Antimicrob Agents Chemother2016
27486777Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus.Am J Hum Genet2016
26866954Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.J Acquir Immune Defic Syndr2016
25803485Correction: Musosal effects for tenofovir 1% gel.Elife2015
26377193A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.Cancer Epidemiol Biomarkers Prev2015
26374103Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.Hum Genomics2015
25919884Correction: Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.PLoS One2015
25713335Mendelian randomization studies for a continuous exposure under case-control sampling.Am J Epidemiol2015
25680424Factors associated with bone mineral density in healthy African women.Arch Osteoporos2015
25651245Tenofovir-based preexposure prophylaxis for HIV infection among African women.N Engl J Med2015
25647729Mucosal effects of tenofovir 1% gel.Elife2015
23813283Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.Biostatistics2014
  • 1 - 50 of 74

Recommended Authors

Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 3
Nicholas B Larson
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 23
Yu-Ru Su
Fred Hutchinson Cancer Center
Career Start Year 2011
Number of shared co-authors 25
Jinyoung Byun
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2009
Number of shared co-authors 26
Jaeil Ahn
Georgetown University
Career Start Year 2008
Number of shared co-authors 2
Xiangjun Xiao
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 15
Lara E Sucheston-Campbell
The Ohio State University
Career Start Year 2007
Number of shared co-authors 43
Simina M Boca
Georgetown University Medical Center
Career Start Year 2007
Number of shared co-authors 11
Jianxin Shi
National Cancer Institute, 9609 Medical Center Drive
Career Start Year 2007
Number of shared co-authors 26
Mengling Liu
NYU Grossman School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Todd L Edwards
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 48
Ni Zhao
Johns Hopkins Bloomberg School of Public Health
Career Start Year 2004
Number of shared co-authors 2
Jiang Gui
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 4
Qi Long
and Informatics Perelman School of Medicine, University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 0
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 3
Joel A Mefford
University of California los angeles
Career Start Year 2001
Number of shared co-authors 0
Andrew S Allen
Duke University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 9
Joshua Millstein
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 11
Ronghui Xu
University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 9
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 6
Hongyu Zhao
Yale University
Career Start Year 1995
Number of shared co-authors 7
Hemant K Tiwari
University of Alabama at Birmingham
Career Start Year 1995
Number of shared co-authors 8
Xihong Lin
Harvard T.H. Chan School of Public Health
Career Start Year 1994
Number of shared co-authors 15
John S Witte
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 39
Ruth M Pfeiffer
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 17
Yudi Pawitan
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 11
Christopher I Amos
Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 59
Sholom Wacholder
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 17

Collaborators

Charles Kooperberg
Co-authored papers 15
Xiaoyu Wang
Fred Hutchison Cancer Center
Co-authored papers 13
Ulrike Peters
Co-authored papers 9
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 8
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 6
Graham G Giles
Co-authored papers 6
Andrew T Chan
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 5
Sonja I Berndt
Co-authored papers 5
Anna H Wu
University of Southern California
Co-authored papers 5
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 5
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 4
Leslie Bernstein
Co-authored papers 4
Elaine A Ostrander
National Cancer Institute
Co-authored papers 4
Alexander P Reiner
Co-authored papers 4
Loic Le Marchand
Co-authored papers 4
Kenneth H Mayer
Co-authored papers 3
Roger L Milne
Co-authored papers 3
Margaret Juliana McElrath
Co-authored papers 3
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 3
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 3
William M Grady
. Fred Hutchinson Cancer Center
Co-authored papers 3
Kristina M Jordahl
University of Washington
Co-authored papers 3
Douglas F Easton
University of Cambridge
Co-authored papers 3
Benjamin A Logsdon
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Raphael Gottardo
Fred Hutchinson Cancer Center
Co-authored papers 3
David A Hinds
23andMe Inc.
Co-authored papers 2
Thomas E Rohan
Albert Einstein College of Medicine
Co-authored papers 2
Janusz Jankowski
Co-authored papers 2
Wei Sun
Co-authored papers 2
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Co-authored papers 2
Release 1.2